Mandate

Vinge has advised D. Carnegie & Co in connection with a directed issue of approximately 6.5 million Class B shares

April 19, 2016

Vinge has advised D. Carnegie & Co AB (publ) (”D. Carnegie”), listed on Nasdaq Stockholm, in connection with the company’s directed cash share issue of 6,539,900 Class B shares at a subscription price of SEK 72.50 per share, raising proceeds of approximately SEK 474,000,000 before transaction costs. The subscription price was determined through an accelerated book-building process. Subscribers in the share issue were approximately 60 Swedish and international institutional investors.

Vinge’s team consisted of Jesper Schönbeck, Sofie Bjärtun and André Isacson.  

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026